New Science Office Deputy Relishes Policy Debates

WASHINGTON—Thomas Rona, confirmed in late November as associate director of the White House Office of Science and Technology Policy, is described in a press release as an electrical engineer with a Sc.D. from MIT. But it is ideas, not objects, that excite him. During a long career at Boeing Aerospace Rona was an anomaly, a self-proclaimed “exotic brain” whose job was to hunt for long range opportunities outside the defense contractor’s normal product line. That search

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

During a long career at Boeing Aerospace Rona was an anomaly, a self-proclaimed “exotic brain” whose job was to hunt for long range opportunities outside the defense contractor’s normal product line. That search stimulated his thinking on broader policy issues, leading to a book, Our Changing Geopolitical Premises, which offered a sweeping analysis of the ills of western society and a four-point prescription for renewed military and political strength. In 1984 he joined the Defense Department to work on intelligence and space policy issues, and in December 1986 he was loaned to OSTP.

The tone of the office, of course, is set by his boss, presidential science adviser William Graham, whom Rona first met when both worked on the Reagan transition team after the 1980 election. But Rona, who shares Graham’s conservative views on strategic and military matters, has seemingly been given some latitude in reaching out to the scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies